- Trials with a EudraCT protocol (9)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
9 result(s) found for: Long Chain Fatty Acids.
Displaying page 1 of 1.
| EudraCT Number: 2019-003276-39 | Sponsor Protocol Number: PR(AG)293/2019 | Start Date*: 2019-11-12 |
| Sponsor Name:VALL HEBRON UNIVERSITY HOSPITAL | ||
| Full Title: Liver impairment recovery related to parenteral nutrition with omega-3 fatty acids: randomized clinical trial. | ||
| Medical condition: Critically ill adult patients with parenteral nutrition and liver parameters altered. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-000705-86 | Sponsor Protocol Number: 01-2020 | Start Date*: 2020-04-26 |
| Sponsor Name:VALL HEBRON UNIVERSITY HOSPITAL | ||
| Full Title: Control of inflammatory parameters with omega-3 fatty acid supplementation in adult patients with parenteral nutrition and respiratory infection by SARS-CoV-2: randomized clinical trial COVID-19 | ||
| Medical condition: Critically ill adult patients with parenteral nutrition and respiratory infection by SARS-COV-2 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-000046-31 | Sponsor Protocol Number: Omega18-13-03 | Start Date*: 2011-11-29 |
| Sponsor Name:The Sahlgrenska Center for Pediatric Ophtalmology Research | ||
| Full Title: A randomised Intervention, Single-Center Study to Determine the Role of Fatty Acids in Serum in preventing Retinopathy of Prematurity | ||
| Medical condition: Premature male/female infants, <28 gestational weeks at birth with risk of developing retinopathy of prematurity (ROP) | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-000322-19 | Sponsor Protocol Number: UX007-CL202 | Start Date*: 2016-06-06 |
| Sponsor Name:Ultragenyx Pharmaceutial Inc. | ||
| Full Title: An Open-label Long-Term Safety and Efficacy Extension Study in Subjects with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Previously Enrolled in UX007 or Triheptanoin Studies | ||
| Medical condition: Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002425-31 | Sponsor Protocol Number: 05-SMOF-006 | Start Date*: 2007-03-19 | |||||||||||
| Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
| Full Title: A double-blind, randomised study comparing the safety and tolerance of SMOFlipid 20% and Intralipid 20% in long-term treatment with parenteral nutrition | |||||||||||||
| Medical condition: Supply of energy, essential fatty acids and omega-3 fatty acids to adults, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) GB (Completed) DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-001684-21 | Sponsor Protocol Number: NV1205-009 | Start Date*: 2018-04-20 |
| Sponsor Name:Neurov Acquisition LLC | ||
| Full Title: Phase I/II, Open-Label, Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of NV1205 in Pediatric Male Subjects with Childhood Cerebral Adrenoleukodystrophy (CCALD) | ||
| Medical condition: Childhood Cerebral Adrenoleukodystrophy (CCALD) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male | |
| Trial protocol: GB (Prematurely Ended) FR (Ongoing) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-020464-38 | Sponsor Protocol Number: PRENU | Start Date*: 2010-06-08 |
| Sponsor Name:University of Oslo | ||
| Full Title: Nutrition, growth and development among very preterm infants | ||
| Medical condition: The main purpose of this study is to evaluate the effect of increased supply of energy, protein, vitamin A and the long chain polyunsaturated fatty acids DHA and AA to Very Low Birth Weight Infants... | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: NO (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000748-16 | Sponsor Protocol Number: MT-2-01 | Start Date*: 2017-09-14 |
| Sponsor Name:Minoryx Therapeutics S.L. | ||
| Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTINATIONAL, MULTICENTER STUDY WITH OPEN-LABEL TREATMENT EXTENSION TO ASSESS THE EFFECT OF MIN-102 ON THE PROGRESSION OF ADRENOMYELONEUROPATHY IN M... | ||
| Medical condition: ADRENOMYELONEUROPATHY IN MALE PATIENTS WITH X-LINKED ADRENOLEUKODYSTROPHY | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) HU (Ongoing) ES (Ongoing) NL (Ongoing) PL (Prematurely Ended) IT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-001145-14 | Sponsor Protocol Number: ALD-104 | Start Date*: 2019-04-17 | |||||||||||
| Sponsor Name:bluebird bio, Inc. | |||||||||||||
| Full Title: A Phase 3 Study of Lenti-D Drug Product After Myeloablative Conditioning Using Busulfan and Fludarabine in Subjects ≤17 Years of Age With Cerebral Adrenoleukodystrophy (CALD) | |||||||||||||
| Medical condition: Cerebral Adrenoleukodystrophy (CALD) | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) FR (Ongoing) DE (Completed) NL (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
